Nov 06, 2018 - Last week's FDA panel rejection of Alkermes depression drug ALKS-5461 all but invalidates the opioid approach to treating MDD, or treatment-resistant depression (TRD).Johnson & Johnson and Allergan ar
Nov 06, 2018 - The health-care sector is in the crosshairs this election season. The results could affect three health-care groups the most, says one market watcher.
Nov 06, 2018 - Eos Focused Equity Management, L.P. Buys Danaher Corp, Platform Specialty Products Corp, Qurate Retail Inc, Sells Pentair PLC, NuVasive Inc, W R Grace, Stocks: MIC,APD,WYND,WH,AGN,AAP,DHR,PAH,QRTEA,VSM,INGR,SER, release date:Nov 06, 2018
Nov 05, 2018 - Ms. Gund is a wealthy white woman who spent a lifetime fighting for racial justice. At 80, she’s the homecoming queen of the philanthropy world. She’s also running out of cash.
Nov 02, 2018 - We see how things are shaping up for the four pharma/biotech companies, which are scheduled to release second-quarter earnings on Nov 5.
Nov 02, 2018 - Teva's (TEVA) shares up 15% despite mixed third-quarter results as it increases its earnings and free cash flow guidance for the full year.
Nov 02, 2018 - Pfizer (PFE) and Allergan (AGN) report third-quarter results. Eli Lilly (LLY), Pfizer and Sanofi (SNY) announce collaboration deals.
Nov 01, 2018 - Jim Cramer issues a warning to investors about the pharmaceutical sector, which includes high-profile stocks like Allergan and Gilead.
Oct 31, 2018 - Jerome Dodson's 3rd Quarter Endeavor Fund Shareholder Letter, Stocks: HBI,MU,QCOM,CVS,GILD,AGN,ADSK,, Jerome Dodson, release date:Oct 31, 2018
Oct 31, 2018 - On Editas' (EDIT) third-quarter conference call, investor focus will be on the company's progress with its proprietary genome editing platform based on CRISPR technology.